Effect of cyclooxygenase-2 and lipoxygenase on progression of prostate cancer
环氧合酶-2和脂氧合酶对前列腺癌进展的影响
基本信息
- 批准号:15591676
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We ligated VEGF promoter of various length in upstream of luciferase gene, transfected these in LNCaP cells, and added PGE2 which was metabolic product by COX-2, and examined VEGF promoter activity.The clear inductive activity was not recognized by PGE2. Next we transfected the vector which joined luciferase gene together in PSA promoter in LNCaP-neo and COX-2 overexpression cell line LNCaP-COX-2, and we added 10-8 M DHT and measured PSA promoter activity. The responsiveness for DHT fell with COX-2 overexpressed cell line. It was suggested that prostate cancer cells become androgen-independent via reduced androgen-responsiveness when COX-2 was overexpressed, in prostatic cancer.When prostate cancer cells were treated with arachidonic acid that was related with fatty acid metabolism, the cell proliferation was stimulated. In order to investigate which metabolites from arachidonic acid are involved in, we examined the effects of COX-2 inhibitors and LOX inhibitors on the proliferation. These inhibitors inhibited the proliferation of irrespective of arachidonic acid, suggesting that arachidonic acid just acts as essential nutrition.We also investigated that sensitivity against anti-cancer drug in COX-2 overexpressing cells. The sensitivity against cisplatin was reduced in COX-2 overexpressing cells. MRP2 induction by COX-2 was involved in this mechanism.
我们在荧光素酶基因上游连接不同长度的VEGF启动子,转染LNCaP细胞,并加入COX-2代谢产物PGE2,检测VEGF启动子活性。PGE2无法识别其明显的诱导活性。接下来,我们在LNCaP-neo和COX-2过表达细胞系LNCaP-COX-2中转染将荧光素酶基因连接在PSA启动子中的载体,加入10-8 M DHT,测定PSA启动子活性。COX-2过表达的细胞系对DHT的反应性下降。这表明,当COX-2在前列腺癌中过度表达时,前列腺癌细胞通过降低雄激素反应性而变得雄激素非依赖性。用与脂肪酸代谢有关的花生四烯酸处理前列腺癌细胞,可促进细胞增殖。为了研究花生四烯酸的哪些代谢物参与其中,我们研究了COX-2抑制剂和LOX抑制剂对增殖的影响。这些抑制剂抑制了花生四烯酸的增殖,表明花生四烯酸只是作为必需的营养物质。我们还研究了COX-2过表达细胞对抗癌药物的敏感性。COX-2过表达细胞对顺铂的敏感性降低。COX-2诱导MRP2参与了这一机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MIZOKAMI Atsushi其他文献
MIZOKAMI Atsushi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MIZOKAMI Atsushi', 18)}}的其他基金
The development of the innovative therapeutic drugs which targete crosstalk in the prostate cancer microenvironment
针对前列腺癌微环境串扰的创新治疗药物的开发
- 批准号:
17H04325 - 财政年份:2017
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Prevention of CRPC and application for docetaxel treatment using flavonoids
CRPC的预防及黄酮类多西紫杉醇治疗的应用
- 批准号:
25462472 - 财政年份:2013
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of androgen-response genes related with the proliferation and development of proliferation-related marker in prostate cancer
前列腺癌中与增殖相关的雄激素反应基因和增殖相关标志物的发育的鉴定
- 批准号:
21592037 - 财政年份:2009
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of progression-related genes in prostate cancer and application to treatment
前列腺癌进展相关基因的鉴定及其在治疗中的应用
- 批准号:
17591669 - 财政年份:2005
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of genes associated with relapse of prostate cancer and gene therapy
与前列腺癌复发相关的基因鉴定和基因治疗
- 批准号:
13671640 - 财政年份:2001
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of mechanism for VEGF expression in renal cell carcinoma
肾细胞癌中VEGF表达的机制分析
- 批准号:
08671852 - 财政年份:1996
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Omega-3 PUFA-gene interaction in prostate cancer
Omega-3 PUFA 与前列腺癌中基因的相互作用
- 批准号:
8215565 - 财政年份:2012
- 资助金额:
$ 2.24万 - 项目类别:
Omega-3 PUFA-gene interaction in prostate cancer
Omega-3 PUFA 与前列腺癌中基因的相互作用
- 批准号:
8607164 - 财政年份:2012
- 资助金额:
$ 2.24万 - 项目类别:
Omega-3 PUFA-gene interaction in prostate cancer
Omega-3 PUFA 与前列腺癌中基因的相互作用
- 批准号:
8434839 - 财政年份:2012
- 资助金额:
$ 2.24万 - 项目类别:
Omega-3 PUFA-gene interaction in prostate cancer
Omega-3 PUFA 与前列腺癌中基因的相互作用
- 批准号:
8815275 - 财政年份:2012
- 资助金额:
$ 2.24万 - 项目类别:
Regulation of prostate cancer cell survival by 5-lipoxygenase:Role of PKC-epsilon
5-脂氧合酶对前列腺癌细胞存活的调节:PKC-ε 的作用
- 批准号:
8331576 - 财政年份:2011
- 资助金额:
$ 2.24万 - 项目类别:
Regulation of prostate cancer cell survival by 5-lipoxygenase:Role of PKC-epsilon
5-脂氧合酶对前列腺癌细胞存活的调节:PKC-ε 的作用
- 批准号:
8517603 - 财政年份:2011
- 资助金额:
$ 2.24万 - 项目类别:
Regulation of prostate cancer cell survival by 5-lipoxygenase:Role of PKC-epsilon
5-脂氧合酶对前列腺癌细胞存活的调节:PKC-ε 的作用
- 批准号:
8184483 - 财政年份:2011
- 资助金额:
$ 2.24万 - 项目类别:
ROLES OF INFLAMMATION AND ANDROGEN METABOLISM IN PROSTATE CANCER DISPARITY
炎症和雄激素代谢在前列腺癌差异中的作用
- 批准号:
7305658 - 财政年份:2007
- 资助金额:
$ 2.24万 - 项目类别:
Inhibition of Eicosanoids in Prostate Cancer by Fish Oil
鱼油对类二十烷酸对前列腺癌的抑制作用
- 批准号:
7152253 - 财政年份:2006
- 资助金额:
$ 2.24万 - 项目类别:
Therapeutic effect of boswellin in prostate cancer
乳香素对前列腺癌的治疗作用
- 批准号:
6711508 - 财政年份:2004
- 资助金额:
$ 2.24万 - 项目类别: